Clinical trial
Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients: a Multicenter Observational Study (INFRAGEN)
NCT06430073 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients: a Multicenter Observational Study (INFRAGEN)
- Lead sponsor
- University Hospital of Ferrara
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 20, 2024
- Completion date
- March 1, 2026
- Enrollment
- 340 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aging, frailty, hospital infection, inflammation, telomere shortening